600 related articles for article (PubMed ID: 25994217)
1. Stromal biology and therapy in pancreatic cancer: a changing paradigm.
Neesse A; Algül H; Tuveson DA; Gress TM
Gut; 2015 Sep; 64(9):1476-84. PubMed ID: 25994217
[TBL] [Abstract][Full Text] [Related]
2. Stromal biology and therapy in pancreatic cancer.
Neesse A; Michl P; Frese KK; Feig C; Cook N; Jacobetz MA; Lolkema MP; Buchholz M; Olive KP; Gress TM; Tuveson DA
Gut; 2011 Jun; 60(6):861-8. PubMed ID: 20966025
[TBL] [Abstract][Full Text] [Related]
3. Stromal biology and therapy in pancreatic cancer: ready for clinical translation?
Neesse A; Bauer CA; Öhlund D; Lauth M; Buchholz M; Michl P; Tuveson DA; Gress TM
Gut; 2019 Jan; 68(1):159-171. PubMed ID: 30177543
[TBL] [Abstract][Full Text] [Related]
4. Stroma and pancreatic ductal adenocarcinoma: an interaction loop.
Luo G; Long J; Zhang B; Liu C; Xu J; Ni Q; Yu X
Biochim Biophys Acta; 2012 Aug; 1826(1):170-8. PubMed ID: 22521638
[TBL] [Abstract][Full Text] [Related]
5. Current and emerging therapies for patients with advanced pancreatic ductal adenocarcinoma: a bright future.
Christenson ES; Jaffee E; Azad NS
Lancet Oncol; 2020 Mar; 21(3):e135-e145. PubMed ID: 32135117
[TBL] [Abstract][Full Text] [Related]
6. Targeting the tumor microenvironment for pancreatic ductal adenocarcinoma therapy.
Zhang YF; Jiang SH; Hu LP; Huang PQ; Wang X; Li J; Zhang XL; Nie HZ; Zhang ZG
Chin Clin Oncol; 2019 Apr; 8(2):18. PubMed ID: 31070038
[TBL] [Abstract][Full Text] [Related]
7. The role of stroma in pancreatic cancer: diagnostic and therapeutic implications.
Erkan M; Hausmann S; Michalski CW; Fingerle AA; Dobritz M; Kleeff J; Friess H
Nat Rev Gastroenterol Hepatol; 2012 Aug; 9(8):454-67. PubMed ID: 22710569
[TBL] [Abstract][Full Text] [Related]
8. Antifibrotic Therapy Disrupts Stromal Barriers and Modulates the Immune Landscape in Pancreatic Ductal Adenocarcinoma.
Elahi-Gedwillo KY; Carlson M; Zettervall J; Provenzano PP
Cancer Res; 2019 Jan; 79(2):372-386. PubMed ID: 30401713
[TBL] [Abstract][Full Text] [Related]
9. Organotypic slice cultures of pancreatic ductal adenocarcinoma preserve the tumor microenvironment and provide a platform for drug response.
Lim CY; Chang JH; Lee WS; Lee KM; Yoon YC; Kim J; Park IY
Pancreatology; 2018 Dec; 18(8):913-927. PubMed ID: 30292644
[TBL] [Abstract][Full Text] [Related]
10. Dynamic Contrast-enhanced MRI Detects Responses to Stroma-directed Therapy in Mouse Models of Pancreatic Ductal Adenocarcinoma.
Cao J; Pickup S; Clendenin C; Blouw B; Choi H; Kang D; Rosen M; O'Dwyer PJ; Zhou R
Clin Cancer Res; 2019 Apr; 25(7):2314-2322. PubMed ID: 30587546
[TBL] [Abstract][Full Text] [Related]
11. Pancreatic cancer stroma: understanding biology leads to new therapeutic strategies.
Rucki AA; Zheng L
World J Gastroenterol; 2014 Mar; 20(9):2237-46. PubMed ID: 24605023
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy.
Sherman MH; Yu RT; Engle DD; Ding N; Atkins AR; Tiriac H; Collisson EA; Connor F; Van Dyke T; Kozlov S; Martin P; Tseng TW; Dawson DW; Donahue TR; Masamune A; Shimosegawa T; Apte MV; Wilson JS; Ng B; Lau SL; Gunton JE; Wahl GM; Hunter T; Drebin JA; O'Dwyer PJ; Liddle C; Tuveson DA; Downes M; Evans RM
Cell; 2014 Sep; 159(1):80-93. PubMed ID: 25259922
[TBL] [Abstract][Full Text] [Related]
13. Use of nano engineered approaches to overcome the stromal barrier in pancreatic cancer.
Meng H; Nel AE
Adv Drug Deliv Rev; 2018 May; 130():50-57. PubMed ID: 29958925
[TBL] [Abstract][Full Text] [Related]
14. Pancreatic stellate cells and pancreas cancer: current perspectives and future strategies.
Haqq J; Howells LM; Garcea G; Metcalfe MS; Steward WP; Dennison AR
Eur J Cancer; 2014 Oct; 50(15):2570-82. PubMed ID: 25091797
[TBL] [Abstract][Full Text] [Related]
15. CD10+ pancreatic stellate cells enhance the progression of pancreatic cancer.
Ikenaga N; Ohuchida K; Mizumoto K; Cui L; Kayashima T; Morimatsu K; Moriyama T; Nakata K; Fujita H; Tanaka M
Gastroenterology; 2010 Sep; 139(3):1041-51, 1051.e1-8. PubMed ID: 20685603
[TBL] [Abstract][Full Text] [Related]
16. Hyaluronan, fluid pressure, and stromal resistance in pancreas cancer.
Provenzano PP; Hingorani SR
Br J Cancer; 2013 Jan; 108(1):1-8. PubMed ID: 23299539
[TBL] [Abstract][Full Text] [Related]
17. Tumor-stromal crosstalk in pancreatic cancer and tissue fibrosis.
Thomas D; Radhakrishnan P
Mol Cancer; 2019 Jan; 18(1):14. PubMed ID: 30665410
[TBL] [Abstract][Full Text] [Related]
18. The pancreas cancer microenvironment.
Feig C; Gopinathan A; Neesse A; Chan DS; Cook N; Tuveson DA
Clin Cancer Res; 2012 Aug; 18(16):4266-76. PubMed ID: 22896693
[TBL] [Abstract][Full Text] [Related]
19. Biology and clinical applications of pancreatic cancer stem cells.
Abel EV; Simeone DM
Gastroenterology; 2013 Jun; 144(6):1241-8. PubMed ID: 23622133
[TBL] [Abstract][Full Text] [Related]
20. The conflicting roles of tumor stroma in pancreatic cancer and their contribution to the failure of clinical trials: a systematic review and critical appraisal.
Bijlsma MF; van Laarhoven HW
Cancer Metastasis Rev; 2015 Mar; 34(1):97-114. PubMed ID: 25566685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
